Last updated on September 2019

ALK5461-217; A Phase 3b Efficacy and Safety Study of Adjunctive ALKS 5461 in Treatment Refractory Major Depressive Disorder

Brief description of study

The main purpose of this study is to see if ALKS 5461 helps treat depression when used together with an antidepressant medication. Other purposes of this study are to learn how safe it is to take ALKS 5461 and to determine how long it stays in the body.

Clinical Study Identifier: TX207249

Find a site near you

Start Over

Pharmacology Research Institute, Los Alamitos

4281 Katella Avenue, Suite 115 Los Alamitos, CA United States
  Connect »